| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.00033 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -2.9e-05 | 1 |